Status:

COMPLETED

The Role of Extended Antral Resection on Weight Loss and Metabolic Response After Sleeve Gastrectomy

Lead Sponsor:

Kocaeli Derince Education and Research Hospital

Conditions:

Bariatric Surgery Candidate

Obesity, Morbid

Eligibility:

All Genders

18-65 years

Brief Summary

Aim: The impact of extended antral resection (AR) after laparoscopic sleeve gastrectomy (LSG) on weight loss changes and metabolic response is still not clearly elucidated with conflicting results. Th...

Detailed Description

Following approval of the ethical committee patients who underwent LSG between January 2016 and June 2018 are retrospectively analyzed. Patients with BMI \> 40 were included. Patients with a history o...

Eligibility Criteria

Inclusion

  • Patients with Body Mass Index \> 40 were included

Exclusion

  • Patients with a history of previous bariatric surgery and patients who did not attend regular follow-up visits (first, 6th and 12 months) are excluded

Key Trial Info

Start Date :

January 1 2016

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 1 2018

Estimated Enrollment :

111 Patients enrolled

Trial Details

Trial ID

NCT04109664

Start Date

January 1 2016

End Date

July 1 2018

Last Update

September 30 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kocaeli Derince Training and research Hospital

Kocasinan, Derince, Turkey (Türkiye), 41900

The Role of Extended Antral Resection on Weight Loss and Metabolic Response After Sleeve Gastrectomy | DecenTrialz